Profarma shareholders BMK, BPL extend exclusivity talks on potential BPL stake sale to Oct. 5

• BMK Participações extended its exclusivity to negotiate buying Profarma shares held by BPL Brazil Holding until Oct. 5, 2026.
• The talks stem from a memorandum of understanding signed on Nov. 4, 2025.
• Any deal remains conditional on negotiating definitive agreements, plus corporate and regulatory approvals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Profarma Distribuidora de Produtos Farmacêuticos SA published the original content used to generate this news brief on August 24, 2026, and is solely responsible for the information contained therein.